biotech
Collaboration between Lilly and CRUK progresses to clinical trials
August 23, 2017Research and Development Cancer Research UK, biotech, drugs, pharma, pharmaceutical
Cancer Research UK has announced that its collaboration with Eli Lilly for the treatment of advanced solid tumours will progress …
Scientists discover ‘Achilles’ heel’ of oesophageal cancer
August 23, 2017Research and Development ICR, Janssen, biotech, drugs, pharma, pharmaceutical
Researchers from The Institute of Cancer Research have potentially found a new use for Imbruvica, after discovering a weakness in …
Ultragenyx stumbles in P3 trial for severe muscle disease
August 23, 2017Research and Development Ultragenyx, biotech, drugs, pharma, pharmaceutical
Ultragenyx has revealed results from a Phase 3 trial into the treatment of GNE myopathy showed that its compound did …
Hikma risks a stratospheric 430% price increase on product
August 22, 2017Manufacturing and Production, Sales and Marketing Hikma, biotech, drugs, generics, pharma, pharmaceutical
It wasn’t so long ago that pharmaceutical companies could change the prices of its products with little scrutiny. A series …
Outcry after private hospitals receive tax breaks instead of NHS
August 22, 2017Manufacturing and Production, Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
It has been revealed that private hospitals being run across England and Wales will receive £52 million in tax breaks …
Taking science and making people feel connected to it
August 21, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, biotech, drugs, pharma, pharmaceutical, rare diseases
Owen Marks, Country Head for the Rare Disease Unit at Pfizer UK, discusses his career so far and what drives …
Antibacterial power of mother’s milk revealed
August 21, 2017Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Researchers from Vanderbilt University have discovered a previously unknown ability of a compound in mother’s milk to protect new-borns from …
Samsung Bioepis collaborates to make inroads into original drugs
August 21, 2017Research and Development, Sales and Marketing Samsung Bioepis, Takeda, biotech, drugs, pharma, pharmaceutical
Thus far, Samsung Bioepis has made its name by being a thorn in the side of the producers of original …
Novartis begins ‘next-generation’ malaria treatment trial
August 21, 2017Research and Development, Sales and Marketing MMV, Novartis, biotech, drugs, malaria, pharma, pharmaceutical
Novartis, alongside Medicines for Malaria Venture (MMV), have revealed that trials into a new antimalarial compound have begun in a …
The pendulum swing of generic drug prices
August 18, 2017Medical Communications biotech, drugs, generics, pharma, pharmaceutical
The prices of generic drugs have been driven lower as companies compete to undercut one another. This has led to …
AZ and MSD secure three bits of good news on key drug
August 18, 2017Medical Communications, Sales and Marketing AstraZeneca, MSD, biotech, drugs, pharma, pharmaceutical
It was a case of three-in-one bits of good news for AstraZeneca and MSD, after the FDA boosted the newly …
Longest-serving chief exec in NHS sacked for ‘gross misconduct’
August 18, 2017Medical Communications NHS, Newcastle, biotech, drugs, pharma, pharmaceutical
Newcastle upon Tyne Hospital’s Chief Executive, Leonard Fenwick, has been sacked from his position after a disciplinary panel adjudged he …
Independent research may change the immunotherapy game
August 17, 2017Research and Development Cancer, biotech, drugs, immunotherapy, pharma, pharmaceutical
Immunotherapy treatments that focus on the PD-L1 protein have become some of the most exciting to emerge in cancer treatment. …
Alexion moves to bolster patent protection of Soliris
August 17, 2017Sales and Marketing Alexion, biotech, drugs, pharma, pharmaceutical, soliris
Soliris brought in net sales of $2.8 billion last year for Alexion, meaning it accounted for close to 90% of …
Cancer Research UK and NU agree three-year research Astex Pharma deal
August 17, 2017Research and Development, Sales and Marketing Astex pharmaceuticals, Cancer Research UK, Newcastle University, biotech, drugs, pharma, pharmaceutical
Cancer Research UK and Newcastle University have announced that their existing research collaboration with Astex Pharmaceuticals will be extended for …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
